Associated Banc-Corp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,026
Closed -$12K 983
2020
Q4
$12K Sell
17,026
-6,073
-26% -$12.9K ﹤0.01% 442
2020
Q3
$52K Sell
23,099
-6,524
-22% -$18.6K ﹤0.01% 366
2020
Q2
$107K Sell
29,623
-727
-2% -$2.62K ﹤0.01% 361
2020
Q1
$116K Buy
30,350
+2,987
+11% +$9.84K 0.01% 344
2019
Q4
$82K Buy
+27,363
New +$71.2K ﹤0.01% 305

Other funds holding BMY.RT

Associated Banc-Corp's BMY.RT Position: Q1 2021 in Review

Associated Banc-Corp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 17,026 shares — an estimated $12K sold.

Associated Banc-Corp first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $116K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Associated Banc-Corp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 17,026 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $12K.
  • Associated Banc-Corp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Associated Banc-Corp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $116K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.